General Info

OraPharma is a specialty pharmaceutical company with an initial product entry in the field of oral health care. The company discovers, develops and commercializes therapeutics for oral health care, oncology and orthopedics. OraPharma's initial product, ARESTIN, represents a promising therapeutic advance for the adjunct treatment of periodontal disease. ARESTIN is the first locally administered time-released antibiotic encapsulated in microspheres that effectively kills the germs that cause periodontal disease or periodontitis, a disease that affects more than 50 million people in the United States. OraPharma is located in Warminster, Pa. The company has approximately 50 employees.